Loading...
XSWX
EVE
Market cap7mUSD
Dec 05, Last price  
0.78CHF
1D
-6.90%
1Q
-24.08%
Jan 2017
-99.49%
IPO
-99.97%
Name

Evolva Holding SA

Chart & Performance

D1W1MN
XSWX:EVE chart
P/E
5.40
P/S
EPS
0.14
Div Yield, %
Shrs. gr., 5y
18.54%
Rev. gr., 5y
1.11%
Revenues
0k
-100.00%
0273,560164,510424,40418,926,68718,628,53011,080,2217,014,4428,706,20010,744,30013,363,6009,575,7006,846,7008,932,60011,596,0007,540,7009,877,60015,539,4009,437,8000
Net income
1m
P
-35,042,040-72,530,960-59,120,280-66,451,549-9,608,907-23,298,866-22,451,971-16,089,948-15,731,900-21,352,900-31,891,900-35,970,700-38,976,900-29,213,900-21,638,900-29,870,200-41,266,400-43,366,400-105,229,4001,044,000
CFO
-2m
L-73.64%
-34,405,780-53,947,330-59,087,490-44,535,168-5,933,657-15,831,343-17,402,435-13,445,766-12,523,800-19,943,700-31,729,200-33,852,300-35,572,900-23,607,000-14,160,500-23,362,700-29,789,200-18,880,700-9,254,500-2,439,300

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
IPO date
May 04, 2005
Employees
50
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT